TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Curcumol, Doxorubicin
Phytochemical Name Curcumol (PubChem CID: 14240392 )
Anticancer drug Name Doxorubicin (PubChem CID: 31703 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 225
Pair Name Curcumol, Doxorubicin
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Gene Regulation Down-regulation Expression ABCC3 hsa8714
Up-regulation Expression MIR181B2 KEGG ID N.A.
Up-regulation Activity NFATC2 hsa4773
In Vitro Model MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
In Vivo Model MDA-MB-231-luc cells were suspended in a 1:1 mixture of saline/Matrigel and injected into the mammary fat pads of six-week-old female nude mice (n = 5 animals; 100 μL and 5×10⁶ cells per animal).
Result Our study provides novel mechanistic evidence for curcumol-mediated sensitization to doxorubicin in TNBC, and it highlights the potential therapeutic usefulness of curcumol as an adjunct drug in TNBC patients with doxorubicin-resistance.
03. Reference
No. Title Href
1 Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis. Biochem Pharmacol. 2020 Apr;174:113795. doi: 10.1016/j.bcp.2020.113795. Click
It has been 26934 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP